Technology
Health
Pharmaceutical
Eisai
$80.949876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$80.94
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.45 (-0.55%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell Eisai and other stocks, options, ETFs, and crypto commission-free!
About
Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. Read More The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan. ESALY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).
CEO
Employees
10,456
Headquarters
Tokyo, Tokyo
Founded
1936
Market Cap
23.31B
Price-Earnings Ratio
40.00
Dividend Yield
1.94
Average Volume
5.02K
High Today
$81.39
Low Today
$79.59
Open Price
$81.39
Volume
1.50K
52 Week High
$101.80
52 Week Low
$62.54
Collections
Technology
Health
Pharmaceutical
Healthcare
Food
Chemicals
Asia (Non-China)
Asia
News
Yahoo FinanceMar 15
Why Eisai (ESALY) Could Be an Impressive Growth Stock
Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well.
Seeking AlphaMar 11
Eisai Co., Ltd. ADR (ESALF) Information Meeting 2019 Conference Call (Transcript)
Eisai Co., Ltd. ADR (OTCPK:ESALF) Information Meeting 2019 Conference Call March 8, 2019 2:00 AM ET Company Participants Haruo Naito - Representative Corporate Officer and CEO Hiroyuki Kobayashi - Medical Division Ryohei Yanagi - CFO Ivan Cheung - SVP, President of Neurology Business Group Dr. Takashi Owa - VP and Chief Medicine Creation Officer & Chief Discovery Officer of Oncology Business Masanori Tsuno - Deputy Chief Clinical Officer of Neurology Business Teiji Kimura - Vice President, Chief Dis...
Price Paid on Robinhood
1% Lower
Right Now
52 Week Low
$62.54
Average Price Paid
$81.63
52 Week High
$101.80